SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Quidel Corporation QDEL recently confirmed the efficacy of its antigen tests concerning continued detection of COVID-19 variants, including Omicron. The company has been at the forefront of the battle ...
Some antigen tests, including the rapid COVID-19 test made by the Abbott BinaxNOW and Quidel QuickVue brands, may fail to detect if you have omicron, according to new data released this week. In ...
(RTTNews) - Quidel Corp. (QDEL) said that its QuickVue At-Home OTC COVID-19 Test and Sofia SARS Antigen FIA are detecting the SARS-CoV-2 Omicron variant. The company said on December 22, the U.S. Food ...
A new study raises significant doubts about whether at-home rapid antigen tests can detect the Omicron variant before infected people can transmit the virus to others. The study looks at 30 people ...
Preliminary evidence suggests that rapid tests like Abbott BinaxNOW and Quidel QuickVue struggle to detect the omicron variant during an individual’s first few days of infection. AzmanL via Getty ...
Add Yahoo as a preferred source to see more of our stories on Google. Rapid tests are a quick and convenient way to learn about your COVID-19 status. The timing, temperature, and even what you eat ...
As COVID-19 case numbers have been slowly rising across the United States, Americans are turning to at-home rapid antigen tests to suss out whether they are sick from a good-old fashioned cold, the ...
Add Yahoo as a preferred source to see more of our stories on Google. Covid-19 at home Rapid Test Kit The FDA has extended the shelf life for some COVID-19 tests. Now that allergy season is here, many ...
As the omicron variant continues to spread across the United States, at-home COVID-19 antigen tests have become an in-demand item. During the holiday season, at-home tests became stocking stuffers.
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results